US Patent 11976297 Engineered immune cells with receptor cross-talk
Patent 11976297 was granted and assigned to A2 Biotherapeutics, Inc on May, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 8 May, 2024
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+218 characters)
US Patent 11976297 Engineered immune cells with receptor cross-talk
Article
Patent abstract
The present disclosure provides engineered immune cells and methods for their creation and use. The immune cells comprise activating and blocking receptors, that exhibit cross-talk between the receptors.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alexander Kamb0
Date of Patent
May 7, 2024
0Patent Application Number
174804660
Date Filed
September 21, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11976297 Engineered immune cells with receptor cross-talk
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
